| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb6372dde89a8ac6af866c273e9f3f8f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-70 |
| filingDate |
2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0250fdd6c04942289b89e3216cf2482e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd23bca10f9928285b940232160c6265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66ae423c066a885f5961d6c61ab259e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb4697cf4c8ca3b21c060ba9e80b2697
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cda24d9029c15084a7afecfdd0c240c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90004cba3d46eb2700defe56f80dd80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efc4abf7e1c7af3d5f3f933a9c837171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f70546175f3ad1b9760d1895af24951 |
| publicationDate |
2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160059177-A |
| titleOfInvention |
Pharmaceutical compositions and health functional foods comprising Persicaria fauriei extracts for preventing or treating anticancer agent-induced of hematopoietic toxicity |
| abstract |
The present invention relates to a method for producing Persicaria The present invention relates to a pharmaceutical composition for the prevention and treatment of hematopoietic toxicity comprising an extract of fauriei as an active ingredient. More particularly, the present invention relates to a pharmaceutical composition for inhibiting hematopoietic toxicity, , And at the same time effectively alleviates the bone marrow toxicity and hematopoietic toxicity induced by the anticancer agent. Therefore, the visible extract can be effectively used as an active ingredient of a pharmaceutical composition for prevention and treatment of anticancer drug induced hematopoietic toxicity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210086806-A |
| priorityDate |
2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |